Question 1

What specific benefits might the VISION5 Product offer compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT01943721). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any risks or side effects associated with the VISION5 Product?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT01943721). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT01943721). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT01943721). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT01943721). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I need to travel to a specific location for treatment or follow-up visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT01943721). Contact the study team or your healthcare provider for specific answers.

What this study is about